Children’s Oncology Group Long-Term Follow-up of Study Participants

ALTE05N1: Umbrella Long-Term Follow-Up Protocol for Participants with and without a History of Cancer

Protocol Description

Through this research initiative, a Long-Term Follow-up Center (LTFC) tracks and collects information from patients who are currently enrolled on or previously participated in a Children's Oncology Group study as they age. The program is intended to help doctors learn more about the long-term effects of cancer treatment, reduce problems related to treatment, and improve patient quality of life.

Eligibility Criteria

This study is enrolling patients of all ages who are participating, or who have participated, in a Children’s Oncology Group study.
Males and Females: All ages


Through this program, the LTFC will reach out to COG trial participants via periodic mailings so that current contact information and health updates can be returned by participants as they get older. The first mailing will occur within the first 3 months of enrollment on this protocol.
Visits: None beyond normal care
Duration: Ongoing

Status: Open to Enrollment

Source(s) of Support

Children’s Oncology Group (ALTE05N1)
National Cancer Institute

Primary Investigator

Jean M. Tersak, MD

Contact Information

For more information about the study, please contact the UPMC Children’s Hospital of Pittsburgh Hematology-Oncology research team, at: